Lung cancer trials in China

In China 1143 Also abroad 2747

1,143 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 4Not yet taking people in China
Rucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed
Where
Changsha
Age
18 years and over
People
29
Run by
Hunan Cancer Hospital
See details and how to joinNCT07674368
No phaseTaking people
DLL3-Targeted PET/CT in Small Cell Lung Cancer
Where
Xiamen
Age
18 years to 80 years
People
20
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07677787
No phaseTaking people
Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 80 years
People
100
Run by
Geneplus-Beijing Co. Ltd.
See details and how to joinNCT05965557
Phase 1Taking people
A Study of DEG6498 in Participants With Solid Tumors
Where
Beijing, Guangzhou
Age
18 years and over
People
100
Run by
Degron Therapeutics Co.
See details and how to joinNCT07244835
No phaseTaking people
RGL-270 + ICI in Advanced NSCLC
Where
Guangzhou
Age
18 years and over
People
40
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT07652125
Early phase 1Not yet taking people in China
A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer
Where
Beijing
Age
18 years to 75 years
People
10
Run by
Beijing Geekgene Technology Co., LTD
See details and how to joinNCT07673419
No phaseNot yet taking people in China
Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
Where
Guangzhou
Age
18 years and over
People
160
Run by
Sun Yat-sen University
See details and how to joinNCT07674524
Phase 1Taking people
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Where
Changchun, Shanghai
Age
18 years and over
People
220 worldwide
Run by
Amgen
See details and how to joinNCT06598306 · EU 2024-511838-12-00
Phase 2Not yet taking people in China
Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response
Where
Tianjin
Age
18 years and over
People
30
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07670715
Phase 2/3Taking people
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
Where
Nanchang
Age
18 years to 85 years
People
30
Run by
Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07131319
No phaseTaking people
Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy
Where
Beijing
Age
18 years and over
People
600
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07668037
No phaseTaking people
Electro-Acupuncture in Lung cancER : EALER Study
Where
Guangzhou, Nanjing
Age
18 years and over
People
424
Run by
Guangzhou University of Traditional Chinese Medicine
See details and how to joinNCT07337096
Phase 2/3Taking people
SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
Where
Guangzhou
Age
18 years and over
People
410
Run by
Sinocelltech Ltd.
See details and how to joinNCT07662395
No phaseTaking people
Effectiveness of Perioperative Percutaneous Acupuncture on Postoperative Sleep Disturbances and Chronic Pain in Patients Undergoing Video-Assisted Thoracoscopic Lung Cancer Resection: A Prospective, Randomized, Single-Blind, Superiority Controlled Trial
Where
Shanghai
Age
18 years to 75 years
People
316
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07662733
Phase 1Taking people
Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
Where
Beijing, Guangzhou, Henan, Shanxi, Shengyang
Age
18 years and over
People
42
Run by
Alpha Biopharma (Jiangsu) Co., Ltd.
See details and how to joinNCT07361705
Phase 2Not yet taking people in China
A Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic ctDNA (MRD) Changes in Locally Advanced or Metastatic EGFR-mutated Non-small Cell Lung Cancer
Where
Hefei
Age
18 years and over
People
154
Run by
Anhui Provincial Cancer Hospital
See details and how to joinNCT07661173
Phase 1/2Taking people
A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
Where
Guangzhou
Age
18 years and over
People
260
Run by
MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07208773
Phase 1/2Taking people
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
Where
Beijing
Age
18 years and over
People
30
Run by
Peking University First Hospital
See details and how to joinNCT07508852
Phase 1/2Taking people
Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression
Where
Nanchang
Age
18 years to 75 years
People
45
Run by
Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07655622
Phase 2Taking people
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib
Where
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Harbin, Hefei, Jinan, Nanjing, Nanning, Shanghai, Shenyang, Wuhan, Xi’an, Zhengzhou
Age
18 years and over
People
86
Run by
Abbisko Therapeutics Co, Ltd
See details and how to joinNCT07164170
Phase 1Not yet taking people in China
Study of SNH-118110 in Advanced Solid Tumors
Where
Shanghai
Age
18 years and over
People
240
Run by
ScinnoHub Pharmaceutical Co., Ltd.
See details and how to joinNCT07649200
Phase 3Taking people
Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer
Where
Hangzhou, Shanghai
Age
18 years to 75 years
People
440
Run by
MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07416994
No phaseNot yet taking people in China
Deep Learning Time-Series Prediction of Long-Term Growth Patterns of Pulmonary Ground-Glass Nodules Using Serial CT
Where
Beijing
Age
18 years and over
People
4,750
Run by
Peking University People's Hospital
See details and how to joinNCT07647692
Phase 2Not yet taking people in China
Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer
Where
Tianjin
Age
18 years to 75 years
People
120
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07358689
Phase 2Taking people
A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
Where
Shanghai
Age
18 years to 75 years
People
28
Run by
Shanghai Chest Hospital
See details and how to joinNCT07091305